Folyóiratcikkek tallózása szerző szerint "SE/AOK/K/II. Sz. Gyermekgyógyászati Klinika"

A találatok rendezése: Rendezés: Találatok:

  • PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer 
    Xu H; Han Y; Lou J; Zhang H; Zhao Y; Győrffy, Balázs; Li R (2017)
    To explore the key genes associated with both PCOS and breast cancer, we overlapped the synchronously differently expressed genes in two obese insulin-resistant GEO datasets in muscle tissue and genes exert essential roles ...
  • Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. 
    Hegyi, Márta; Arany, Ádám; Semsei, Ágnes F; Csordas, Katalin; Eipel, Olivér; Gézsi, András; Kutszegi, Nóra; Csóka, Monika; Müller, Judit; Erdélyi, Dániel; Antal, Péter; Szalai, Csaba; Kovács, Gábor (2017)
    Inter-individual differences in toxic symptoms and pharmacokinetics of high-dose methotrexate (MTX) treatment may be caused by genetic variants in the MTX pathway. Correlations between polymorphisms and pharmacokinetic ...
  • Pharmacogenetics of anthracyclines. 
    C. Sági, Judit; Kutszegi N; Kelemen A; Fodor LE; Gézsi, András; Kovács, Gábor; Erdélyi, Dániel; Szalai, Csaba; Semsei, Ágnes F (2016)
    Anthracyclines constitute a fundamental part of the chemotherapy regimens utilized to treat a number of different malignancies both in pediatric and adult patients. These drugs are one of the most efficacious anticancer ...
  • Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia 
    C. Sági, Judit; Gézsi, András; Egyed, Bálint; Jakab, Zsuzsanna; Benedek, Noémi; Attarbaschi, Andishe; Köhrer, Stefan; Sipek, Jakub; Winkowska, Lucie; Zaliova, Marketa; Anastasopoulou, Stavroula; Wolthers, Benjamin Ole; Ranta, Susanna; Szalai, Csaba; Kovács, Gábor; Semsei, Ágnes F; Erdélyi, Dániel (2021)
  • Pharmacokinetics, pharmacodynamics, and safety of moss-aGalactosidase A in patients with Fabry disease 
    Hennermann, Julia B; Arash-Kaps, Laila; Fekete, György; Schaaf, Andreas; Busch, Andreas; Frischmuth, Thomas (2019)
    Moss-aGalactosidase A (moss-aGal) is a moss-derived version of human α-galactosidase developed for enzyme replacement therapy in patients with Fabry disease. It exhibits a homogenous N-glycosylation profile with >90% ...
  • Polymorphisms of the ApoE, HSD3B1, IL-1 beta and p53 genes are associated with the development of early uremic complications in diabetic patients 
    Szőke D; Molnár, Béla; Solymosi, Norbert; Rácz, Károly; Gergics, Péter; Blaskó, Bernadett; Vásárhelyi, Barna; Vannay, Ádám; Mándy Y; Klausz, Gergely; Gyulai, Zsófia; Udvardyné Galamb, Orsolya; Spisák, Sándor; Hutkai B; Somogyi, Anikó; Berta K; Szabó, András; Tulassay, Tivadar; Tulassay, Zsolt (2009)
    Genetic polymorphisms of the genes involved in angiogenesis, the inflammatory cascade or apoptosis control can influence the chronic complications of diabetic patients. Parallel evaluation of multiple genetic polymorphisms ...
  • Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis 
    Hasselblatt M; Thomas C; Hovestadt V; Schrimpf D; Johann P; Johann P; Bens S; Oyen F; Peetz-Dienhart S; Crede Y; Wefers A; Vogel H; Riemenschneider MJ; Antonelli M; Giangaspero F; Bernardo MC; Giannini C; Ud Din N; Perry A; Keyvani K; van Landeghem F; Sumerauer D; Hauser, Péter; Capper D; Korshunov A; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Fruhwald MC; Kool M (2016)
  • Poszttranszplantációs lymphoproliferativ betegség gyermekkorban 
    Stréhn Anita,; Szőnyi, László; Kriván, Gergely; Kovács, Lajos; Reusz, György; Szabó, Attila; Rényi, Imre; Kovács, Gábor; Dezsőfi, Antal (2014)
    Bevezetés: A poszttranszplantációs lymphoproliferativ betegség a leggyakoribb szolid szerv- vagy allogén vérképző őssejt-transzplantációt követően kialakuló malignitás gyermekkorban. E széles spektrumú betegség immunszuppresszió ...
  • Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency. 
    Luczay, Andrea; Török, Dóra; Ferenczi A; Majnik Judit, Zsuzsanna; Sólyom, János; Fekete, György (2006)
    OBJECTIVE: Congenital adrenal hyperplasia (CAH) shows a range of severity which is explained in part by the different mutations of the CYP21 gene. To better understand the incomplete concordance between genotype and phenotype ...
  • Potential options for managing LOX+ ER- breast cancer patients 
    Han Y; Lian S; Cui X; Meng K; Győrffy, Balázs; Jin T; Huang D (2016)
  • Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis 
    Jiang T; Shi W; Wali VB; Pongor, Lőrinc; Li C; Lau R; Győrffy, Balázs; Lifton RP; Symmans WF; Pusztai L; Hatzis C (2016)
    Background: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic ...
  • Pregnancy outcome in idiopathic inflammatory myopathy 
    Váncsa, Andrea; Ponyi, Andrea; Constantin, Tamás; Zeher, Margit; Dankó, Katalin (2007)
    The aim of our study was to assess the prevalence and outcome of pregnancy in idiopathic inflammatory myopathy patients who became pregnant after the onset of the disease. Female idiopathic inflammatory myopathy patients ...
  • Prenatal diagnosis of steroid 21-hydroxylase deficiency by allele-specific amplification 
    Theodoropoulou M; Barta, Csaba; Szoke M; Guttman, András; Staub M; Niederland T; Sólyom, János; Fekete, György; Sasvári-Székely, Mária (2001)
  • Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma 
    Al-Halabi H; Nantel A; Klekner, Álmos; Guiot MC; Albrecht S; Hauser, Péter; Garami, Miklós; Bognár, László; Kavan P; Gerges N; Shirinian M; Roberge D; Muanza T; Jabado N (2011)
  • Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin lymphoma 
    Rényi, Imre; Bárdi, Edit; Udvardi E; Kovács, Gábor; Bartyik K; Kajtár P; Masát P; Nagy K; Galántai I; Kiss, Csongor (2007)
  • Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature 
    Balogh, Petra; Bánusz, Rita; Csóka, Monika; Váradi, Zsófia; Varga, Edit; Sápi, Zoltán (2016)
    BACKGROUND: Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin and comprises the largest category of soft-tissue sarcomas both in children and adolescents. From a pediatric oncology point of view, RMS has ...
  • Primer immundeficiencia - komplementdefektus. Laborvizsgálatok bemutatása egy betegünk kapcsán 
    Szilágyi, Ágnes; Varga, Lilian; Prohászka, Zoltán; Dérfalvi, Beáta (2014)
  • Prognostic value of DLGAP5 in colorectal cancer 
    Branchi, V; García, SA; Radhakrishnan, P; Győrffy, Balázs; Hissa, B; Schneider, M; Reißfelder, C; Schölch, S (2019)
    DLG7 (disc large homolog 7) is a microtubule-associated protein encoded by DLGAP5 (DLG associated protein 5) gene and has an important role during spindle assembly. Spindle assembly deregulation is a well-known cause of ...
  • Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 
    Thompson, EM; Hielscher, T; Bouffet, E; Remke, M; Luu, B; Gururangan, S; McLendon, RE; Bigner, DD; Lipp, ES; Perreault, S; Cho, YJ; Grant, G; Kim, SK; Lee, JY; Rao, AA; Giannini, C; Li, KK; Ng, HK; Yao, Y; Kumabe, T; Tominaga, T; Grajkowska, WA; Perek-Polnik, M; Low, DC; Seow, WT; Chang, KT; Mora, J; Pollack, IF; Hamilton, RL; Leary, S; Moore, AS; Ingram, WJ; Hallahan, AR; Jouvet, A; Fevre-Montange, M; Vasiljevic, A; Faure-Conter, C;; Shofuda, T; Kagawa, N; Hashimoto, N; Jabado, N; Weil, AG; Gayden, T; Wataya, T; Shalaby, T; Grotzer, M; Zitterbart, K; Sterba, J; Kren, L; Hortobágyi, Tibor; Klekner, Álmos; Laszlo, B; Pócza, Tímea; Hauser, Péter; Schuller, U; Jung, S; Jang, WY; French, PJ; Kros, JM; van Veelen, MC; Massimi, L; Leonard, JR; Rubin, JB; Vibhakar, R; Chambless, LB; Cooper, MK; Thompson, RC; Faria, CC; Carvalho, A; Nunes, S; Pimentel, J; Fan, X; Muraszko, KM; Lopez-Aguilar, E; Lyden, D; Garzia, L; Shih, DJ; Kijima, N; Schneider, C; Adamski, J; Northcott, PA; Kool, M; Jones, DT; Chan, JA; Nikolic, A; Garre, ML; Van, Meir EG; Osuka, S; Olson, JJ; Jahangiri, A; Castro, BA; Gupta, N; Weiss, WA; Moxon-Emre, I; Mabbott, DJ; Lassaletta, A; Hawkins, CE; Tabori, U; Drake, J; Kulkarni, A; Dirks, P; Rutka, JT; Korshunov, A; Pfister, SM; Packer, RJ; Ramaswamy, V; Taylor, MD (2016)
    BACKGROUND: Patients with incomplete surgical resection of medulloblastoma are controversially regarded as having a marker of high-risk disease, which leads to patients undergoing aggressive surgical resections, so-called ...
  • Prognostic value of PDCD-1 and CTLA-4 in ovarian cancer patients 
    Zhu CJ; Ma XL; Ling WW; Xiao Y; Győrffy, Balázs (2016)
    Therapeutic effectiveness of treatments for ovarian cancer is not optimal. PDCD-1 and CTLA-4 offers the potential as a prognostic marker in addition to being a target for therapy. To assess the prognostic roles of PDCD-1 ...